GO:0005851 eukaryotic translation initiation factor 2B complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005851 describes the eukaryotic translation initiation factor 2B (eIF2B) complex, a multisubunit guanine nucleotide exchange factor (GEF) that converts inactive eIF2-GDP into active eIF2-GTP.
• In humans, eIF2B is composed of five subunits (alpha, beta, delta, gamma and epsilon) encoded by EIF2B1-EIF2B5, and its architecture has been resolved by crystallography.
• The beta/Gcd7 subunit is crucial for binding eIF2 in vivo, linking the GEF catalytic core to its substrate.
• eIF2B is the central regulatory node of the integrated stress response (ISR): phosphorylation of eIF2alpha inhibits eIF2B, reducing global protein synthesis while favoring stress-adaptive translation.
• Loss-of-function mutations in EIF2B genes cause vanishing white matter disease, a fatal leukodystrophy, making the complex a direct disease target.
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of eIF2B subunit function in translation control and disease.
Description
The eukaryotic translation initiation factor 2B (eIF2B) complex, annotated as GO:0005851, is a multisubunit guanine nucleotide exchange factor that catalyzes the exchange of GDP bound to initiation factor eIF2 for GTP, thereby regenerating active eIF2-GTP for each round of translation initiation. Because eIF2 delivers the initiator methionyl-tRNA to the 40S ribosomal subunit, the activity of eIF2B sets the rate at which cells can initiate protein synthesis. The complex is therefore a focal point for translational control in health and disease. Biochemical and structural work has established that eIF2B is a decameric assembly of five distinct subunits, alpha, beta, delta, gamma and epsilon, whose catalytic center resides in the epsilon subunit. The beta/Gcd7 subunit is essential for stable binding of eIF2 in vivo, coupling substrate recruitment to catalysis. This architecture explains why mutations in individual subunits produce dominant or recessive disease phenotypes. For researchers, GO:0005851 is more than a static component: it is the convergence point of nutrient, stress and immune signaling pathways that tune protein synthesis. Understanding how eIF2B is assembled, regulated and hijacked in disease requires precise genetic models, which is why CRISPR-based approaches are now central to the field.
eukaryotic translation initiation factor 2B complex At A Glance
| GO ID | GO:0005851 |
|---|---|
| GO term | eukaryotic translation initiation factor 2B complex |
| Ontology | cellular_component |
| Synonym | eif2B, eIF-2B |
| Major function | Guanine nucleotide exchange factor (GEF) that converts eIF2-GDP to eIF2-GTP |
| Subunit composition | Five subunits: alpha, beta, delta, gamma and epsilon |
| Catalytic subunit | eIF2B epsilon contains the GEF catalytic domain |
| Key substrate | eIF2 (initiation factor 2) |
| Regulatory input | Inhibited by phosphorylated eIF2alpha during the integrated stress response |
What Is GO:0005851?
GO:0005851 (eukaryotic translation initiation factor 2B complex) is a cellular component term describing a multisubunit guanine nucleotide exchange factor that catalyzes the exchange of GDP bound to initiation factor eIF2 for GTP, generating active eIF2-GTP. In humans, the complex is composed of five subunits: alpha, beta, delta, gamma and epsilon.
Why Is eukaryotic translation initiation factor 2B complex Important in Cell Biology?
eIF2B is the rate-limiting guanine nucleotide exchange factor for translation initiation, and its activity determines how much protein a cell can synthesize under normal and stressed conditions. Because it is inhibited by phosphorylated eIF2alpha, eIF2B is the central effector of the integrated stress response, a pathway that reprograms translation during nutrient deprivation, ER stress, viral infection and oxidative stress. Mutations in EIF2B subunits cause vanishing white matter disease, and dysregulation of eIF2B has been implicated in cancer, neurodegeneration and metabolic disease. Consequently, eIF2B is both a fundamental research subject and a therapeutic target.
• Controls the rate-limiting step of translation initiation by regenerating eIF2-GTP.
• Serves as the master regulator of the integrated stress response through inhibition by phospho-eIF2alpha.
• Its five-subunit architecture provides a model for GEF complex assembly and allostery.
• Mutations in EIF2B1-EIF2B5 cause vanishing white matter disease, a fatal leukodystrophy.
• Modulates selective translation of stress-responsive mRNAs such as ATF4.
• Is a candidate target for small-molecule ISR inhibitors in neurodegeneration and cancer.
• Its beta/Gcd7 subunit is required for eIF2 binding in vivo, defining subunit-specific functions.
• Provides a paradigm for studying translation control using ribosome profiling and proteomics.
• Links nutrient sensing (mTOR) and stress signaling to protein synthesis.
• Offers CRISPR-tractable targets for disease modeling and drug discovery.
Structure, Assembly and Molecular Mechanism of the eukaryotic translation initiation factor 2B complex
Subunit architecture and decameric assembly
In simple terms: eIF2B is built from five different proteins that come together in pairs to form a large machine.
The human eIF2B complex is composed of five subunits, alpha, beta, delta, gamma and epsilon, which assemble into a decameric complex. Crystallographic analysis revealed the overall architecture and provided a structural framework for understanding how the subunits cooperate. The epsilon subunit harbors the catalytic guanine nucleotide exchange domain, while the other subunits contribute to substrate binding and regulation.
Substrate recognition and eIF2 binding
In simple terms: The complex must grab eIF2 to exchange its GDP for GTP.
The beta/Gcd7 subunit of eIF2B is crucial for binding eIF2 in vivo, and loss of this subunit impairs the guanine nucleotide exchange reaction. This substrate recruitment step is distinct from catalysis and is required for efficient GDP/GTP exchange on eIF2. Structural and biochemical studies have mapped the interaction surfaces between eIF2B and eIF2.
Catalytic GDP/GTP exchange
In simple terms: eIF2B acts like a switch that replaces a used battery (GDP) with a fresh one (GTP) on eIF2.
eIF2B catalyzes the exchange of GDP bound to eIF2 for GTP, generating active eIF2-GTP. This reaction is essential because eIF2-GTP is the form that binds Met-tRNAi and delivers it to the 40S ribosome. The catalytic activity resides in the epsilon subunit, and the reaction is tightly regulated by phosphorylation of eIF2alpha.
Inhibition by phosphorylated eIF2alpha
In simple terms: When eIF2 is phosphorylated, it sticks to eIF2B and blocks its activity.
Phosphorylation of eIF2alpha converts eIF2 into a competitive inhibitor of eIF2B, reducing guanine nucleotide exchange and global protein synthesis. This inhibition is the core mechanism of the integrated stress response, which allows selective translation of stress-responsive mRNAs such as ATF4. Termination of the ISR requires dephosphorylation of eIF2alpha and restoration of eIF2B activity.
Assembly and quality control of the complex
In simple terms: The cell builds eIF2B step by step and checks that all parts are present.
Stepwise assembly of the eIF2 complex and its partners ensures stoichiometric production of translation initiation factors. Studies of eIF2B biogenesis indicate that subunit availability and assembly are coordinated with cellular demand for translation. Disruption of assembly leads to loss of GEF activity and activation of stress responses.
Key Genes Involved in GO:0005851 eukaryotic translation initiation factor 2B complex
The following genes encode the subunits and principal regulators of the eukaryotic translation initiation factor 2B complex and its substrate eIF2.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF2B1 | Encodes eIF2B alpha subunit | Mutations cause vanishing white matter disease; subunit-specific functions |
| EIF2B2 | Encodes eIF2B beta subunit | Disease-linked; contributes to complex assembly |
| EIF2B3 | Encodes eIF2B gamma subunit | Disease-linked; structural component |
| EIF2B4 | Encodes eIF2B delta subunit | Disease-linked; modulates GEF activity |
| EIF2B5 | Encodes eIF2B epsilon catalytic subunit | Contains GEF catalytic domain; hotspot for mutations |
| EIF2S1 | Encodes eIF2 alpha subunit | Phosphorylation site Ser51 regulates eIF2B inhibition |
| EIF2S2 | Encodes eIF2 beta subunit | Forms eIF2 complex with alpha and gamma |
| EIF2S3 | Encodes eIF2 gamma subunit | Binds GTP and Met-tRNAi |
| GCN2 (EIF2AK4) | Kinase that phosphorylates eIF2alpha | Activates ISR under amino acid starvation |
| PERK (EIF2AK3) | ER stress kinase phosphorylating eIF2alpha | Links ER stress to eIF2B inhibition |
| PKR (EIF2AK2) | Double-stranded RNA-activated eIF2alpha kinase | Antiviral ISR activation |
| HRI (EIF2AK1) | Heme-regulated eIF2alpha kinase | Erythroid stress response |
| PPP1R15A (GADD34) | Regulatory subunit of PP1 phosphatase | Dephosphorylates eIF2alpha to terminate ISR |
| PPP1R15B (CReP) | Constitutive PP1 regulatory subunit | Maintains basal eIF2alpha phosphorylation |
| ATF4 | Stress-induced transcription factor | Selectively translated when eIF2B is inhibited |
| DDIT3 (CHOP) | Pro-apoptotic transcription factor | Downstream of ATF4 during prolonged ISR |
| MTOR | Nutrient-sensing kinase | Regulates translation initiation globally |
How Is eukaryotic translation initiation factor 2B complex Regulated?
eIF2B activity is regulated primarily by phosphorylation of its substrate eIF2alpha. Four stress-activated kinases, GCN2, PERK, PKR and HRI, phosphorylate eIF2alpha at Ser51, converting eIF2 into a competitive inhibitor of eIF2B and suppressing global translation while permitting selective translation of ATF4. Termination of the integrated stress response requires dephosphorylation of eIF2alpha by PP1 complexes containing PPP1R15A (GADD34) or PPP1R15B (CReP), which restores eIF2B activity. In addition, nutrient and growth factor signaling through mTOR modulates translation initiation capacity, indirectly influencing eIF2B-dependent steps. The complex is also regulated at the level of subunit assembly and availability, as stepwise assembly ensures stoichiometric production of initiation factors.
eukaryotic translation initiation factor 2B complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIF2B5 | Vanishing white matter disease | Knock-in of patient mutations in iPSC-derived oligodendrocytes |
| EIF2B2 | Vanishing white matter disease | CRISPR knockout in HeLa or HEK293T cells |
| EIF2S1 | Neurodegeneration via ISR | Ser51Ala point mutation knock-in in neurons |
| PPP1R15A | ISR termination defects | Knockout in mouse embryonic fibroblasts |
| ATF4 | Cancer stress adaptation | Overexpression in cancer cell lines |
Vanishing white matter disease
Biallelic mutations in EIF2B1-EIF2B5 cause vanishing white matter disease, a progressive leukodystrophy characterized by loss of white matter and neurological decline. Disease mutations typically impair guanine nucleotide exchange activity or complex stability, leading to chronic activation of the integrated stress response in oligodendrocytes and astrocytes. The severity of disease correlates with residual eIF2B activity, making the complex a direct therapeutic target.
Neurodegeneration and the integrated stress response
Chronic activation of the integrated stress response, driven by persistent eIF2alpha phosphorylation and eIF2B inhibition, contributes to neurodegeneration in conditions such as Alzheimer's disease and prion disease. Small-molecule ISR inhibitors that restore eIF2B activity are being explored as neuroprotective agents. Termination of the ISR by GADD34/CReP-mediated dephosphorylation is critical for neuronal survival.
Cancer and metabolic stress
Tumor cells frequently exploit the integrated stress response to survive nutrient deprivation and hypoxia, and eIF2B activity supports the translation of pro-survival factors such as ATF4. Targeting eIF2B or upstream kinases is therefore an active area of cancer research. Metabolic stress in diabetes and obesity also engages eIF2B-dependent translational control.
From eukaryotic translation initiation factor 2B complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of eIF2B epsilon abolish GEF activity? | CRISPR knockout of EIF2B5 in HEK293T cells |
| Does Ser51 phosphorylation of eIF2alpha mediate eIF2B inhibition? | Point mutation knock-in of EIF2S1 S51A |
| Can disease mutations be corrected by gene editing? | Knock-in of wild-type EIF2B5 in patient iPSCs |
| Where does eIF2B localize in cells? | Tagged knock-in of EIF2B2 with fluorescent protein |
| Does eIF2B overexpression enhance translation? | Overexpression of EIF2B5 in cell lines |
| Which subunits are essential for complex assembly? | CRISPR knockout of each EIF2B subunit |
How to Study the eukaryotic translation initiation factor 2B complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Genome-wide translation efficiency | Detect selective translation under eIF2B inhibition |
| RNA-seq | Transcript abundance | Identify ISR target gene expression changes |
| Phosphoproteomics | eIF2alpha phosphorylation | Monitor ISR activation |
| Cryo-EM | Complex structure | Determine subunit architecture |
| Immunoblotting | Protein levels and phosphorylation | Validate eIF2B subunit expression |
| Polysome profiling | Ribosome-mRNA association | Assess translation initiation defects |
| Guanine nucleotide exchange assay | GEF activity | Measure eIF2B catalytic function |
Ribosome profiling (Ribo-seq)
Ribo-seq measures genome-wide translation by sequencing ribosome-protected mRNA fragments, allowing researchers to quantify how eIF2B activity affects global and transcript-specific translation. It is particularly useful for detecting selective translation of stress-responsive mRNAs such as ATF4 when eIF2B is inhibited.
RNA sequencing and transcriptomics
RNA-seq reveals changes in gene expression that accompany eIF2B perturbation, including activation of ISR target genes. Combined with Ribo-seq, it distinguishes transcriptional from translational regulation.
Proteomics and phosphoproteomics
Mass spectrometry-based proteomics quantifies eIF2B subunit abundance and assembly, while phosphoproteomics monitors eIF2alpha phosphorylation status. These methods are essential for linking genotype to signaling output.
Structural biology and imaging
Crystallography and cryo-EM have resolved the eIF2B complex architecture, and fluorescence imaging of tagged subunits reveals subcellular localization and assembly dynamics. These approaches complement genetic studies.
How CRISPR Can Be Used to Study GO:0005851 eukaryotic translation initiation factor 2B complex
Knockout
CRISPR knockout of individual EIF2B subunits, such as EIF2B5 or EIF2B2, abolishes guanine nucleotide exchange activity and activates the integrated stress response, providing a clean loss-of-function model to study subunit-specific roles. Knockout cells can be used to test rescue by wild-type or mutant subunits.
Point Mutation
Point mutation knock-in of disease-associated alleles in EIF2B1-EIF2B5 or of the EIF2S1 Ser51Ala phospho-dead variant allows precise dissection of how specific residues control GEF activity and ISR signaling. These models are invaluable for understanding genotype-phenotype relationships in vanishing white matter disease.
Knock-in
Tagged knock-in of eIF2B subunits with fluorescent or affinity tags enables live-cell imaging and proteomic isolation of the complex, revealing assembly dynamics and interaction partners. Knock-in of wild-type EIF2B5 into patient-derived iPSCs can correct disease-causing mutations.
Overexpression
Overexpression of eIF2B subunits or of constitutively active variants increases guanine nucleotide exchange capacity and enhances translation initiation, providing gain-of-function models to test whether eIF2B activity is rate-limiting. Such models are useful for studying stress resistance and protein synthesis capacity.
How EDITGENE Supports eukaryotic translation initiation factor 2B complex Research
Researchers studying eukaryotic translation initiation factor 2B complex-related genes often need to determine whether a candidate gene is causally involved in translation control, stress adaptation or disease. Rigorous causal inference requires precise genetic models in which individual subunits or regulatory sites are altered without confounding off-target effects. EDITGENE provides end-to-end CRISPR services tailored to eIF2B biology, from knockout to knock-in and library screening.
Contact EDITGENE today to design your custom CRISPR model for eukaryotic translation initiation factor 2B complex research.
Frequently Asked Questions About eukaryotic translation initiation factor 2B complex
What is the eukaryotic translation initiation factor 2B complex?
It is a multisubunit guanine nucleotide exchange factor that converts eIF2-GDP to eIF2-GTP, annotated as GO:0005851.
What genes are involved in the eukaryotic translation initiation factor 2B complex?
The complex is encoded by EIF2B1, EIF2B2, EIF2B3, EIF2B4 and EIF2B5, which produce the alpha, beta, delta, gamma and epsilon subunits.
What is the function of eIF2B in translation?
eIF2B catalyzes GDP/GTP exchange on eIF2, regenerating active eIF2-GTP for each round of translation initiation.
How is eIF2B regulated?
It is inhibited by phosphorylated eIF2alpha during the integrated stress response and restored by PP1-mediated dephosphorylation.
What diseases are linked to eIF2B mutations?
Mutations in EIF2B1-EIF2B5 cause vanishing white matter disease, a fatal leukodystrophy.
What is the integrated stress response?
It is a translational reprogramming pathway in which eIF2alpha phosphorylation inhibits eIF2B, reducing global translation while favoring ATF4 translation.
How can I study eIF2B with CRISPR?
Knockout, point mutation, knock-in and overexpression models allow causal dissection of subunit function and regulation.
What is the structure of eIF2B?
It is a decameric complex of five subunits whose architecture has been resolved by crystallography.
Which subunit of eIF2B binds eIF2?
The beta/Gcd7 subunit is crucial for binding eIF2 in vivo.
How is the integrated stress response terminated?
Dephosphorylation of eIF2alpha by PP1 complexes containing GADD34 or CReP restores eIF2B activity.
Conclusion
The eukaryotic translation initiation factor 2B complex (GO:0005851) is the central guanine nucleotide exchange factor that sustains translation initiation and serves as the master regulator of the integrated stress response. Its five-subunit architecture, catalytic mechanism and disease relevance make it a compelling subject for structural, biochemical and genetic research. CRISPR-based models are now indispensable for linking eIF2B genotype to cellular phenotype and for developing therapies for vanishing white matter disease and other stress-related disorders.
References
- 1. Vanselow S et al.. 2022. Stepwise assembly of the eukaryotic translation initiation factor 2 complex.. J Biol Chem 298(2):101583 PMID: 35031321
- 2. De Miguel C et al.. 2026. Termination of the integrated stress response.. Science 391(6787):eadw5137 PMID: 41231936
- 3. Kashiwagi K et al.. 2016. Crystal structure of eukaryotic translation initiation factor 2B.. Nature 531(7592):122-5 PMID: 26901872
- 4. Webb BL et al.. 1997. Eukaryotic initiation factor 2B (eIF2B).. Int J Biochem Cell Biol 29(10):1127-31 PMID: 9438375
- 5. Wek RC et al.. 2023. Surviving and Adapting to Stress: Translational Control and the Integrated Stress Response.. Antioxid Redox Signal 39(4-6):351-373 PMID: 36943285
- 7. Dev K et al.. 2010. The beta/Gcd7 subunit of eukaryotic translation initiation factor 2B (eIF2B), a guanine nucleotide exchange factor, is crucial for binding eIF2 in vivo.. Mol Cell Biol 30(21):5218-33 PMID: 20805354
- 8. Jennings MD et al.. 2014. A new function and complexity for protein translation initiation factor eIF2B.. Cell Cycle 13(17):2660-5 PMID: 25486352
